ONCO vs. SXTP, CYTO, NTBL, AGRX, ARDS, SNOA, CWBR, DRMA, SLRX, and CMND
Should you be buying Onconetix stock or one of its competitors? The main competitors of Onconetix include 60 Degrees Pharmaceuticals (SXTP), Altamira Therapeutics (CYTO), Notable Labs (NTBL), Agile Therapeutics (AGRX), Aridis Pharmaceuticals (ARDS), Sonoma Pharmaceuticals (SNOA), CohBar (CWBR), Dermata Therapeutics (DRMA), Salarius Pharmaceuticals (SLRX), and Clearmind Medicine (CMND). These companies are all part of the "pharmaceutical preparations" industry.
Onconetix (NASDAQ:ONCO) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, community ranking, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.
60 Degrees Pharmaceuticals received 1 more outperform votes than Onconetix when rated by MarketBeat users.
60 Degrees Pharmaceuticals has a consensus price target of $2.40, indicating a potential upside of 805.32%. Given 60 Degrees Pharmaceuticals' higher probable upside, analysts clearly believe 60 Degrees Pharmaceuticals is more favorable than Onconetix.
23.9% of Onconetix shares are held by institutional investors. Comparatively, 8.0% of 60 Degrees Pharmaceuticals shares are held by institutional investors. 19.5% of Onconetix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
60 Degrees Pharmaceuticals has higher revenue and earnings than Onconetix. 60 Degrees Pharmaceuticals is trading at a lower price-to-earnings ratio than Onconetix, indicating that it is currently the more affordable of the two stocks.
60 Degrees Pharmaceuticals' return on equity of 0.00% beat Onconetix's return on equity.
In the previous week, 60 Degrees Pharmaceuticals had 5 more articles in the media than Onconetix. MarketBeat recorded 8 mentions for 60 Degrees Pharmaceuticals and 3 mentions for Onconetix. 60 Degrees Pharmaceuticals' average media sentiment score of 0.63 beat Onconetix's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.
Summary
60 Degrees Pharmaceuticals beats Onconetix on 10 of the 14 factors compared between the two stocks.
Get Onconetix News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ONCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Onconetix Competitors List
Related Companies and Tools
